Alternative affinity tools: More attractive than antibodies?

Biochemical Journal

Volumn 436, Issue 1, 2011, Pages 1-13

  Ruigrok, Vincent J B ^a   Levisson, Mark ^a,b   Eppink, Michel H M ^a   Smidt, Hauke ^a   Van Der Oost, John ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Dutch Separation Technology Institute   (Netherlands)

Author keywords

Affinity tool; Antibody; Aptamer; Engineered binding protein; Molecular imprinted polymer

Indexed keywords

ANTIBODY; APTAMER; BINDING PROTEIN;

BINDING AFFINITY; HUMAN; MOLECULAR IMPRINTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ENGINEERING; REVIEW;

ANIMALS; ANTIBODIES; APTAMERS, NUCLEOTIDE; CARRIER PROTEINS; CHROMATOGRAPHY, AFFINITY; DRUG DELIVERY SYSTEMS; HUMANS; MOLECULAR IMPRINTING; NUCLEIC ACIDS; PROTEIN ENGINEERING;

EID: 79955540113     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101860     Document Type: Review

References (131)

1. Hoogenboom, H. R. (2005) Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23, 1105-1116 (Pubitemid 41486392)
2. Binz, H. K., Amstutz, P. and Plückthun, A. (2005) Engineering novel binding proteins from nonimmunoglobulin domains. Nat. Biotechnol. 23, 1257-1268 (Pubitemid 41486853)
3. Kontermann, R., Dübel, S. and Storz, U. (2010) IP issues in the therapeutic antibody industry. In Antibody Engineering, pp. 517-581, Springer, Berlin
4. Kohler, G. and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497
5. Chiarella, P. and Fazio, V. M. (2008) Mouse monoclonal antibodies in biological research: strategies for high-throughput production. Biotechnol. Lett. 30, 1303-1310
6. Nelson, A. L., Dhimolea, E. and Reichert, J. M. (2010) Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discovery 9, 767-774
7. Reichert, J. M. (2008) Monoclonal antibodies as innovative therapeutics. Curr. Pharm. Biotechnol. 9, 423-430
8. Zahirul Khan, I. M., Opdebeeck, J. P. and Tucker, I. G. (1994) Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress. Pharm. Res. 11, 2-11 (Pubitemid 24040757)
9. Chambers, R. S. and Johnston, S. A. (2003)High-level generation ofpolyclonal antibodies by genetic immunization. Nat. Biotechnol. 21, 1088-1092 (Pubitemid 37064740)
10. Ning, Y., Wang, Y., Li, Y., Hong, Y., Peng, D., Liu, Y., Wang, J., Hao, W., Tian, X., Wu, F. et al. (2006) An alternative strategy for high throughput generation and characterization of monoclonal antibodies against human plasma proteins using fractionated native proteins as immunogens. Proteomics 6, 438-448 (Pubitemid 43208023)
11. Browne, S. M. and Al-Rubeai, M. (2007) Selection methods for high-producing mammalian cell lines. Trends Biotechnol. 25, 425-132
12. De Masi, F., Chiarella, P., Wilhelm, H., Massimi, M., Bullard, B., Ansorge, W. and Sawyer, A. (2005) High throughput production of mouse monoclonal antibodies using antigen microarrays. Proteomics 5, 4070-4081 (Pubitemid 41626075)
13. Zichi, D., Eaton, B., Singer, B. and Gold, L. (2008) Proteomics and diagnostics: Let's Get Specific, again. Curr. Opin. Chem. Biol. 12, 78-85
14. Cabrera, H. A. (1969) A comprehensive evaluation of pregnancy tests. Am. J. Obstet. Gynecol. 103, 32-38
15. Von Lode, P. (2005) Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clin. Biochem. 38, 591-606 (Pubitemid 40961628)
16. Branson, B. M. (2004) FDA approves OraQuickfor use in saliva. On March 25, the FDA approved the first rapid testfor HIV in oral fluids. AIDS Clin. Care 16, 39
17. Goldstein, G., Schindler, J. and Tsai, H. (1985) A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N. Engl. J. Med. 313, 337-342 (Pubitemid 15046364)
18. Waldmann, T. A. (2003) Immunotherapy: past, present and future. Nat. Med. 9, 269-277 (Pubitemid 36362781)
19. Beck, A., Wurch, T., Bailly, C. and Corvaia, N. (2010) Strategies and challenges for the next generation of therapeutic antibodies. Nat. Rev. Immunol. 10, 345-352
20. Lonberg, N. (2008) Fully human antibodies from transgenic mouse and phage display platforms. Curr. Opin. Immunol. 20, 450-159
21. Lutterotti, A. and Martin, R. (2008) Getting specific: monoclonal antibodies in multiple sclerosis. Lancet Neurol. 7, 538-547 (Pubitemid 351657494)
22. Wu, A. M. and Senter, P. D. (2005) Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol. 23, 1137-1146 (Pubitemid 41486395)
23. Food and Drug Administration (2010) FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg from U.S. Market, http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm216448.htm
24. Carter, P. J. (2006) Potent antibody therapeutics by design. Nat. Rev. Immunol. 6, 343-357
25. Holliger, P. and Hudson, P. J. (2005) Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23, 1126-1136 (Pubitemid 41486394)
26. Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E. B., Bendahman, N. and Hamers, R. (1993) Naturally occurring antibodies devoid of light chains. Nature 363, 446-148
27. Stanfield, R. L., Dooley, H., Flajnik, M. F. and Wilson, I. A. (2004) Crystal structure of a shark single-domain antibody V region in complex with lysozyme. Science 305, 1770-1773 (Pubitemid 39249643)
28. Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., Cauerhff, A., Danquah, W., Rissiek, B., Scheuplein, F. et al. (2009) Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med. Microbiol. Immunol. 198, 157-174
29. Harmsen, M. M. and De Haard, H. J. (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77, 13-22 (Pubitemid 47573319)
30. Zafra, O., Fraile, S., Gutiérrez, C., Haro, A., Páez-Espino, A. D., Jiménez, J. I. and de Lorenzo, V. (2011) Monitoring biodegradative enzymes with nanobodies raised in Camelus dromedarius with mixtures of catabolic proteins. Environ. Microbiol., doi:10.1111/j.1462- 2920.2010.02401.x
31. Sidhu, S. S. and Koide, S. (2007) Phage display for engineering and analyzing protein interaction interfaces. Curr. Opin. Struct. Biol. 17, 481-487 (Pubitemid 47451773)
32. Daugherty, P. S. (2007) Protein engineering with bacterial display. Curr. Opin. Struct. Biol. 17, 474-480 (Pubitemid 47451767)
33. Gai, S. A. and Wittrup, K. D. (2007) Yeast surface display for protein engineering and characterization. Curr. Opin. Struct. Biol. 17, 467-473 (Pubitemid 47454774)
34. Zahnd, C., Amstutz, P. and Pluckthun, A. (2007) Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat. Methods 4, 269-279 (Pubitemid 46358879)
35. Lipovsek, D. and Plückthun, A. (2004) In-vitro protein evolution by ribosome display and mRNA display. J. Immunol. Methods 290, 51-67 (Pubitemid 38917130)
36. Paschke, M. (2006) Phage display systems and their applications. Appl. Microbiol. Biotechnol. 70, 2-11 (Pubitemid 43234524)
37. Sidhu, S. S. (2001) Engineering M13 for phage display. Biomol. Eng. 18, 57-63 (Pubitemid 32776595)
38. Kehoe, J. W. and Kay, B. K. (2005) Filamentous phage display in the new millennium. Chem. Rev. 105, 4056-4072 (Pubitemid 41724069)
39. Pande, J., Szewczyk, M. M. and Grover, A. K. (2010) Phage display: concept, innovations, applications and future. Biotechnol. Adv. 28, 849-858
40. Bratkoviĉ, T. (2010) Progress in phage display: evolution of the technique and its applications. Cell. Mol. Life Sci. 67, 749-767
41. Montiel, C. and Bustos-Jaimes, I. (2008) Trends and challenges in directed evolution. Curr. Chem. Biol. 2, 50-59 (Pubitemid 351486268)
42. Nygren, P. Å. and Skerra, A. (2004) Binding proteins from alternative scaffolds. J. Immunol. Methods 290, 3-28 (Pubitemid 38922856)
43. Hey, T., Fiedler, E., Rudolph, R. and Fiedler, M. (2005) Artificial, non-antibody binding proteins for pharmaceutical and industrial applications. Trends Biotechnol. 23, 514-522 (Pubitemid 41317915)
44. Gill, D. S. and Damle, N. K. (2006) Biopharmaceutical drug discovery using novel protein scaffolds. Curr. Opin. Biotechnol. 17, 653-658 (Pubitemid 44802987)
45. Hosse, R. J., Rothe, A. and Power, B. E. (2006) A new generation of protein display scaffolds for molecular recognition. Protein Sci. 15, 14-27 (Pubitemid 43004229)
46. Skerra, A. (2007) Alternative non-antibody scaffolds for molecular recognition. Curr. Opin. Biotechnol. 18, 295-304 (Pubitemid 47385180)
47. Grönwall, C. and Ståhl, S. (2009) Engineered affinity proteins: generation and applications. J. Biotechnol. 140, 254-269
48. Nuttall, S. D. and Walsh, R. B. (2008) Display scaffolds: protein engineering for novel therapeutics. Curr. Opin. Pharmacol. 8, 609-615
49. Park, S. J. and Cochran, J. R. (2010), Protein Engineering and Design, CRC Press, Boca Raton
50. Bloom, L. and Calabro, V. (2009) FN3: a new protein scaffold reaches the clinic. Drug Discovery Today 14, 949-955
51. Koide, A., Bailey, C. W., Huang, X. and Koide, S. (1998) The fibronectin type III domain as a scaffold for novel binding proteins. J. Mol. Biol. 284, 1141-1151 (Pubitemid 28558562)
52. Xu, L., Aha, P., Gu, K., Kuimelis, R. G., Kurz, M., Lam, T., Lim, A. C., Liu, H., Lohse, P. A., Sun, L. et al. (2002) Directed evolution of high-affinity antibody mimics using mRNA display. Chem. Biol. 9, 933-942 (Pubitemid 35240913)
53. Stumpp, M. T., Binz, H. K. and Amstutz, P. (2008) DARPins: a new generation of protein therapeutics. Drug Discovery Today 13, 695-701
54. Stumpp, M. T. and Amstutz, P. (2007) DARPins: a true alternative to antibodies. Curr. Opin. Drug Discovery Dev. 10, 153-159 (Pubitemid 46438644)
55. Binz, H. K., Amstutz, P., Kohl, A., Stumpp, M. T., Briand, C., Forrer, P., Gruutter, M. G. and Pluckthun, A. (2004) High-affinity binders selected from designed ankyrin repeat protein libraries. Nat. Biotechnol. 22, 575-582 (Pubitemid 38590636)
56. Vogel, M., Keller-Gautschi, E., Baumann, M. J., Amstutz, P., Ruf, C., Kricek, F. and Stadler, B. M. (2007) Designed ankyrin repeat proteins as anti-idiotypic-binding molecules. Ann. N.Y. Acad. Sci. 1109, 9-18 (Pubitemid 47511339)
57. Unsworth, L. D., Van Der Oost, J. and Koutsopoulos, S. (2007) Hyperthermophilic enzymes: stability, activity and implementation strategies for high temperature applications. FEBS J. 274, 4044-4056 (Pubitemid 47228643)
58. Gomes, J. and Steiner, W. (2004) The biocatalytic potential of extremophiles and extremozymes. Food Technol. Biotechnol. 42, 223-235 (Pubitemid 40048679)
59. Taussig, M. J., Stoevesandt, O., Borrebaeck, C. A. K., Bradbury, A. R., Cahill, D., Cambillau, C., de Daruvar, A., Dubel, S., Eichler, J., Frank, R. et al. (2007) ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat. Methods 4, 13-17 (Pubitemid 46029466)
60. Mann, D., Reinemann, C, Stoltenburg, R. and Strehlitz, B. (2005) In vitro selection of DNA aptamers binding ethanolamine. Biochem. Biophys. Res. Commun. 338, 1928-1934 (Pubitemid 41643110)
61. Bruno, J. G., Carrillo, M. P, Phillips, T. and King, B. (2008) Development of DNA aptamers for cytochemical detection of acetylcholine. In Vitro Cell. Dev. Biol. Anim. 44, 63-72
62. Tuerk, C. and Gold, L. (1990) Systemic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510
63. Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H. and Toole, J. J. (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564-566
64. Cao, X. X., Li, S. H., Chen, L. C., Ding, H. M., Xu, H., Huang, Y. P., Li, J., Liu, N. L., Cao, W. H., Zhu, Y. J. et al. (2009) Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus. Nucleic Acids Res. 37, 4621-1628
65. Tang, Z. W., Shangguan, D., Wang, K. M., Shi, H., Sefah, K., Mallikratchy, P., Chen, H. W., Li, Y. and Tan, W. H. (2007) Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem. 79, 4900-4907 (Pubitemid 47051443)
66. Jenison, R. D., Gill, S. C., Pardi, A. and Polisky, B. (1994) High-resolution molecular discrimination by RNA. Science 263, 1425-1429 (Pubitemid 24137828)
67. Ellington, A. D. and Szostak, J. W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822
68. Wilson, C. and Szostak, J. W. (1995) In vitro evolution of a self-alkylating ribozyme. Nature 374, 777-782
69. Mendonsa, S. D. and Bowser, M. T. (2004) In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal. Chem. 76, 5387-5392 (Pubitemid 39249420)
70. Stoltenburg, R., Reinemann, C. and Strehlitz, B. (2005) FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal. Bioanal. Chem. 383, 83-91 (Pubitemid 41549245)
71. Stoltenburg, R., Reinemann, C. and Strehlitz, B. (2007) SELEX: a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol. Eng. 24, 381-403 (Pubitemid 47391579)
72. Jhaveri, S., Rajendran, M. and Ellington, A. D. (2000) In vitro selection of signaling aptamers. Nat. Biotechnol. 18, 1293-1297
73. Oh, S. S., Plakos, K., Lou, X., Xiao, Y. and Soh, H. T. (2010) In vitro selection of structure-switching, self-reporting aptamers. Proc. Natl. Acad. Sci. U.S.A. 107, 14053-14058
74. Kato, T., Takemura, T., Yano, K., Ikebukuro, K. and Karube, I. (2000) Invitro selection of DNAaptamers which bind to cholic acid. Biochim. Biophys. 1493, 12-18
75. Bing, T., Yang, X., Mei, H., Cao, Z. and Shangguan, D. (2010) Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. Bioorg. Med. Chem. 18, 1798-1805
76. Drolet, D. W., Moon-McDermott, L. and Romig, T. S. (1996) An enzyme-linked oligonucleotide assay. Nat. Biotechnol. 14, 1021-1027 (Pubitemid 26286579)
77. Tyagi, S. and Kramer, F. R. (1996) Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol. 14, 303-308
78. Martí, A. A., Jockusch, S., Li, Z., Ju, J. and Turro, N. J. (2006) Molecular beacons with intrinsically fluorescent nucleotides. Nucleic Acids Res. 34, e50
79. Baker, B. R., Lai, R. Y., Wood, M. S., Doctor, E. H., Heeger, A. J. and Plaxco, K. W. (2006) An electronic, aptamer-based small-molecule sensor for the rapid, label-free detection of cocaine in adulterated samples and biological fluids. J. Am. Chem. Soc. 128, 3138-3139
80. Li, D., Song, S. and Fan, C. (2010) Target-responsive structural switching for nucleic acid-based sensors. Acc. Chem. Res. 43, 631-641
81. Javaherian, S., Musheev, M. U., Kanoatov, M., Berezovski, M. V. and Krylov, S. N. (2009) Selection of aptamers for a protein target in cell lysate and their application to protein purification. Nucleic Acids Res. 37, e62
82. Ruta, J., Ravelet, C., Désiré, J., Décout, J. L. and Peyrin, E. (2008) Covalently bonded DNA aptamer chiral stationary phase for the chromatographic resolution of adenosine. Anal. Bioanal. Chem. 390, 1051-1057 (Pubitemid 351207803)
83. Gragoudas, E. S., Adamis, A. P., Cunningham, Jr, E. T., Feinsod, M. and Guyer, D. R. (2004) Pegaptanib for neovascular age-related macular degeneration. NewEngl. J. Med. 351, 2805-2816 (Pubitemid 40051904)
84. Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, Jr, E. T., Guyer, D. R. and Adamis, A. P. (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discovery 5, 123-132
85. Keefe, A. D., Pai, S. and Ellington, A. (2010) Aptamers as therapeutics. Nat. Rev. Drug Discovery 9, 537-550
86. Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E., Gill, S. C., Magallanez, A. and Knauer, S. (1998) Liposome-anchored vascular endothelial growth factor aptamers. Bioconjugate Chem. 9, 573-582
87. Wu, Y., Sefah, K., Liu, H., Wang, R. and Tan, W. (2010) DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells. Proc. Natl. Acad. Sci. U.S.A. 107 , 5-10
88. McNamara, II, J. O., Andrechek, E. R., Wang, Y, Viles, K. D., Rempel, R. E., Gllboa, E., Sullenger, B. A. and Glangrande, P H. (2006) Cell type-specific delivery of siRNAs with aptamer-slRNA chimeras. Nat. Biotechnol. 24, 1005-1015 (Pubitemid 44215395)
89. Dassie, J. P., Liu, X. Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O. and Giangrande, P. H. (2009) Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat. Biotechnol. 27, 839-846
90. Zhou, J., Swiderski, P., Li, H., Zhang, J., Neff, C. P., Akkina, R. and Rossi, J. J. (2009) Selection, characterization and application of new RNA HIV gp120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells. Nucleic Acids Res. 37, 3094-3109
91. Keeney, T. R., Bock, C., Gold, L., Kraemer, S., Lollo, B., Nikrad, M., Stanton, M., Stewart, A., Vaught, J. D. and Walker, J. J. (2009) Automation of the SomaLogic proteomics assay: a platform for biomarker discovery. JALA 14, 360-366
92. Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T. et al. (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. 5, e15004
93. Mairal, T., Cengiz Özalp, V., Lozano Sánchez, P., Mir, M., Katakis, I. and O'Sullivan, C. K. (2008) Aptamers: molecular tools for analytical applications. Anal. Bioanal. Chem. 390, 989-1007 (Pubitemid 351207799)
94. Cox, J. C., Hayhurst, A., Hesselberth, J., Bayer, T. S., Georgiou, G. and Ellington, A. D. (2002) Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res. 30, e108
95. Cruz-Aguado, J. A. and Penner, G. (2008) Determination of ochratoxin A with a DNA aptamer. J. Agric. Food Chem. 56, 10456-10461
96. Missailidis, S. and Hardy, A. (2009) Aptamers as inhibitors of target proteins. Expert Opin. Ther. Pat. 19, 1073-1082
97. Thiel, K. (2004) Oligo oligarchy: the surprisingly small world of aptamers. Nat. Biotechnol. 22, 649-651 (Pubitemid 38702809)
98. Mayer, G. (2009) The chemical biology of aptamers. Angew. Chem. Int. Ed. 48, 2672-2689
99. Keefe, A. D. and Cload, S. T. (2008) SELEX with modified nucleotides. Curr. Opin. Chem. Biol. 12, 448-456
100. Klussmann, S., Nolte, A., Bald, R., Erdmann, V. A. and Förste, J. P. (1996) Mirror-image RNA that binds D-adenosine. Nat. Biotechnol. 14, 1112-1115 (Pubitemid 26299110)
101. Vaught, J. D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J., Waugh, S., Wilcox, S. K. and Eaton, B. E. (2010) Expanding the chemistry of DNA for in vitro selection. J. Am. Chem. Soc. 132, 4141-4151
102. Dickey, F. H. (1949) The preparation of specific adsorbents. Proc. Natl. Acad. Sci. U.S.A. 35, 227-229
103. Mayes, A. G. and Whitcombe, M.J. (2005) Synthetic strategies for the generation of molecularly imprinted organic polymers. Adv. Drug Delivery Rev. 57, 1742-1778 (Pubitemid 41643048)
104. Spivak, D. A. (2005) Optimization, evaluation, and characterization of molecularly imprinted polymers. Adv. Drug Delivery Rev. 57, 1779-1794 (Pubitemid 41643049)
105. Ge, Y. and Turner, A. P. F. (2008) Too large to fit? Recent developments in macromolecular imprinting. Trends Biotechnol. 26, 218-224
106. Shi, H., Tsal, W. B., Garrison, M. D., Ferrari, S. and Ratner, B. D. (1999) Template-imprinted nanostructured surfaces for protein recognition. Nature 398, 593-597 (Pubitemid 29183682)
107. Takeuchi, T. and Hishiya, T. (2008) Molecular imprinting of proteins emerging as a tool for protein recognition. Org. Biomol. Chem. 6, 2459-2467 (Pubitemid 351950574)
108. Karim, K., Breton, F., Rouillon, R., Piletska, E. V., Guerreiro, A., Chianella, I. and Piletsky, S. A. (2005) How to find effective functional monomers for effective molecularly imprinted polymers? Adv. Drug Delivery Rev. 57, 1795-1808 (Pubitemid 41643050)
109. Batra, D. and Shea, K. J. (2003) Combinatorial methods in molecular imprinting. Curr. Opin. Chem. Biol. 7, 434-442 (Pubitemid 36782372)
110. Takeuchi, T., Fukuma, D. and Matsui, J. (1999) Combinatorial molecular imprinting: an approach to synthetic polymer receptors. Anal. Chem. 71, 285-290
111. Ye, L. and Mosbach, K. (2008) Molecular imprinting: Synthetic materials as substitutes for biological antibodies and receptors. Chem. Mat. 20, 859-868 (Pubitemid 351315684)
112. Ge, Y. and Turner, A. P. F. (2009) Molecularly imprinted sorbent assays: recent developments and applications. Chem. Eur. J. 15, 8100-8107
113. Turiel, E. and Martín-Esteban, A. (2010) Molecularly imprinted polymers for sample preparation: a review. Anal. Chim. Acta 668, 87-99
114. Chapuis, F., Pichon, V., Lanza, F., Sellergren, S. and Hennion, M. C. (2003) Optimization of the class-selective extraction of triazines from aqueous samples using a molecularly imprinted polymer by a comprehensive approach of the retention mechanism. J. Chromatogr. A 999, 23-33 (Pubitemid 36638497)
115. Vlatakis, G., Andersson, L. I., Muller, R. and Mosbach, K. (1993) Drug assay using antibody mimics made by molecular imprinting. Nature 361, 645-647 (Pubitemid 23062398)
116. Holthoff, E. L. and Bright, F. V. (2007) Molecularly templated materials in chemical sensing. Anal. Chim. Acta 594, 147-161 (Pubitemid 46935066)
117. Rathbone, D. L. (2005) Molecularly imprinted polymers in the drug discovery process. Adv. Drug Delivery Rev. 57, 1854-1874 (Pubitemid 41643053)
118. Cederfur, J., Pei, Y., Zihui, M. and Kempe, M. (2003) Synthesis and screening of a molecularly imprinted polymer library targeted for penicillin G.J. Comb. Chem. 5, 67-72 (Pubitemid 37130452)
119. Yu, Y., Ye, L., Haupt, K. and Mosbach, K. (2002) Formation of a class of enzyme inhibitors (drugs), including a chiral compound, by using imprinted polymers or biomolecules as molecular-scale reaction vessels. Angew. Chem. Int. Ed. 41, 4459-4463 (Pubitemid 35462387)
120. Patek, M. and Drew, M. (2008) Chemical synthesis in nanosized cavities. Curr. Opin. Chem. Biol. 12, 332-339
121. Huval, C. C., Bailey, M. J., Braunlin, W. H., Holmes-Farley, S. R., Mandeville, W. H., Petersen, J. S., Polomoscanik, S. C., Sacchiro, R. J., Chen, X. and Dhal, P. K. (2001) Novel cholesterol lowering polymeric drugs obtained by molecular imprinting. Macromolecules 34, 1548-1550 (Pubitemid 34216524)
122. Hoshino, Y., Koide, H., Urakami, T., Kanazawa, H., Kodama, T., Oku, N. and Shea, K. J. (2010) Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody. J. Am. Chem. Soc. 132, 6644-6645
123. Franco, E. J., Sonneson, G. J., DeLegge, T. J., Hofstetter, H., Horn, J. R. and Hofstetter, O. (2010) Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878, 177-186
124. Clark, S. L. and Remcho, V. T. (2002) Aptamers as analytical reagents. Electrophoresis 23, 1335-1340 (Pubitemid 34567365)
125. Romig, T. S., Bell, C. and Drolet, D. W. (1999) Aptamer affinity chromatography: combinatorial chemistry applied to protein purification. J. Chromatogr. B Biomed. Sci. Appl. 731, 275-284 (Pubitemid 29397594)
126. Oktem, H. A., Bayramoglu, G., Ozalp, V. C. and Arica, M. Y. (2007) Single-step purification of recombinant Thermusaquaticus DNA polymerase using DNA-aptamer immobilized novel affinity magnetic beads. Biotechnol. Prog. 23, 146-154 (Pubitemid 46293498)
127. Yingfu, L., Yi, L., Ravelet, C. and Peyrin, E. (2009) Aptamers in affinity separations: stationary separation. In Functional Nucleic Acids for Analytical Applications, pp. 271-286, Springer, New York
128. Zourob, M., Elwary, S., Turner, A., Warriner, K., Lai, E. P. C., Namvar, A., Hawkins, D. M. and Reddy, S. M. (2008) Molecular imprinted polymers for biorecognition of bioagents. In Principles of Bacterial Detection: Biosensors, Recognition Receptors and Microsystems, pp. 785-814, Springer, New York
129. Hober, S., Nord, K. and Linhult, M. (2007) Protein A chromatography for antibody purification J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 848, 40-47 (Pubitemid 46367767)
130. McCauley, T. G., Hamaguchi, N. and Stanton, M. (2003) Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. Anal. Biochem. 319, 244-250 (Pubitemid 36842733)
131. Wojcik, J., Hantschel, O., Grebien, F., Kaupe, I., Bennett, K. L., Barkinge, J., Jones, R. B., Koide, A., Superti-Furga, G. and Koide, S. (2010) A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat. Struct. Mol. Biol. 17, 519-527